| Nov 17 |
Omega Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
|
| Nov 15 |
Omega Therapeutics reports Q3 results
|
| Nov 14 |
Omega Therapeutics, Inc. (OMGA) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 14 |
Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results
|
| Oct 29 |
Oculis Holding AG (OCS) Moves 7.9% Higher: Will This Strength Last?
|
| Oct 23 |
Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence
|
| Oct 15 |
Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings
|
| Oct 3 |
Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors
|
| Sep 17 |
Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications
|
| Aug 14 |
Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research
|
